Biochemical and immunologic predictors of efficacy of treatment or reinfection risk for Schistosoma mansoni

8Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Most Schistosoma mansoni infections are egg-negative after a single dose of oxamniquine. A cohort of 661 infected children was treated at 6-month intervals and assessed for nutritional and parasitological status. Initial biochemical and immunologic markers were measured in a subset of 84 children. All were treated at the start of therapy and at 6 months. Immunoglobulins only served as markers for active infection. No markers were predictive of cure or reinfection, except initial infection intensity and serum low-density lipoprotein. Ten percent were persistently infected and had no change in infection intensity at any time-point. Several factors suggest that this group was biologically different. In addition to failing to reduce their worm burden, they had significantly higher initial intensity of infection (100 versus 65 eggs/g, P = 0.001) and significantly lower initial serum low-density lipoprotein (72 versus 104 mg/dL, P = 0.045). The biologic plausibility of this observation is discussed. Copyright © 2006 by The American Society of Tropical Medicine and Hygiene.

Cite

CITATION STYLE

APA

Reis, E. A. G., Reis, M. G., Silva, R. D. C. R., Carmo, T. M. A., Assis, A. M. O., Barreto, M. L., … Blanton, R. E. (2006). Biochemical and immunologic predictors of efficacy of treatment or reinfection risk for Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 75(5), 904–909. https://doi.org/10.4269/ajtmh.2006.75.904

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free